TRIB3 confers radiotherapy resistance in esophageal squamous cell carcinoma by stabilizing TAZ
- 10 March 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Oncogene
- Vol. 39 (18), 3710-3725
- https://doi.org/10.1038/s41388-020-1245-0
Abstract
Radioresistance becomes the major obstacle to reduce tumor recurrence and improve prognosis in the treatment of esophageal squamous cell carcinoma (ESCC). Thus new strategies for radioresistant ESCC are urgently needed. Herein, we reported that tribbles pseudokinase 3 (TRIB3) serves as a key regulator of radioresistance in ESCC. TRIB3 is overexpressed in ESCC tissues and cell lines. High expression of TRIB3 significantly correlates with poor radiotherapy response and prognosis in ESCC patients. Upregulation of TRIB3 in ESCC cells conferred radioresistance in vitro and in vivo by interacting with TAZ thus impeding β-TrCP-mediated TAZ ubiquitination and degradation. Conversely, silencing TRIB3 sensitized ESCC cells to ionizing radiation. More importantly, TRIB3 was significantly correlated with TAZ activation in ESCC biopsies, and patients with high expression of both TRIB3 and TAZ suffered the worst radiotherapy response and survival. Our study uncovers the critical mechanism of ESCC resistance to radiotherapy, and provides a new pharmacological opportunity for developing a mechanism-based strategy to eliminate radioresistant ESCC in clinical practice.Funding Information
- National Natural Science Foundation of China (81672854, 81530082, 81773106)
This publication has 53 references indexed in Scilit:
- The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant gliomaGenes & Development, 2011
- Oncogenic YAP promotes radioresistance and genomic instability in medulloblastoma through IGF2-mediated Akt activationOncogene, 2011
- Tribbles homolog 3 denotes a poor prognosis in breast cancer and is involved in hypoxia responseBreast Cancer Research, 2011
- The Hippo Tumor Pathway Promotes TAZ Degradation by Phosphorylating a Phosphodegron and Recruiting the SCFβ-TrCP E3 Ligase*Journal of Biological Chemistry, 2010
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene, 2010
- Abnormal expression of TRIB3 in colorectal cancer: a novel marker for prognosisBritish Journal of Cancer, 2009
- TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal TransitionJournal of Biological Chemistry, 2009
- Treatment of Radioresistant Stem-Like Esophageal Cancer Cells by an Apoptotic Gene-Armed, Telomerase-Specific Oncolytic AdenovirusClinical Cancer Research, 2008
- TAZ Promotes Cell Proliferation and Epithelial-Mesenchymal Transition and Is Inhibited by the Hippo PathwayMolecular and Cellular Biology, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006